Product Center
Products Center
Objective To observe the therapeutic effect of Bairui Granules in adjuvant treatment of children with Mycoplasma pneumoniae pneumonia. Methods July 2014 to 2015 In July 2009, 100 children with MPP who were admitted to the Department of Pediatrics of the Second Affiliated Hospital of Shenyang Medical College were randomly divided into the observation group and the control group with 50 cases in each group. right The control group was given sequential treatment with erythromycin and azithromycin on the basis of conventional symptomatic treatment, and the observation group was given Bairui Granules orally on the basis of the control group. compare two The total effective rate of clinical treatment, fever reduction time, cough disappearance time, lung rales disappearance time, and adverse reactions in the group were compared. result observation The total effective rate in the treatment group was 94% (47/50), which was significantly higher than 80% (40/50) in the control group, and the difference was statistically significant (P<0.05). Fever in the observation group The time, cough disappearance time and lung rales disappearance time were significantly shorter than those of the control group, and the differences were statistically significant (P<0.05). Differences in the two groups of patients The incidence of adverse reactions was similar, and the difference was not statistically significant (P>0.05). Conclusion The adjuvant treatment of Bairui granule in children with Mycoplasma pneumoniae pneumonia can significantly reduce the incidence of pneumonia in children. Improve clinical efficacy, significantly improve symptoms and signs, the treatment is safe and effective, worthy of clinical promotion.
2021-10-19
Ⅰ. The company won the title of "2020 Law-abiding and Integrity Enterprise in China's Pharmaceutical Industry"
Ⅱ. The company has won the list of "2020 Chinese National Pharmaceutical Excellent Brand Enterprises"
Ⅲ. The planting base of Pleurotus is identified as the "Top Ten Anhui Medicines" Industrial Demonstration Base
Ⅳ. The company entered the top 100 Chinese traditional medicine enterprises in 2020
Ⅴ.Bairui Granules and Yuye Jinhua Qingre Tablets appeared at the National "Thirteenth Five-Year" Science and Technology Innovation Achievement Exhibition
Ⅵ. Baimeixing® Bairui Granules entered the "2021 China Pharmaceutical Brand List"
2021-09-14
Ⅰ. The company was selected as the construction unit of the "Top Ten Anhui Medicines" industrial demonstration bases.
Ⅱ. The company was rated as "Provincial Key Leading Enterprise of Agricultural Industrialization".
Ⅲ. Ranked in the TOP100 list of Chinese traditional Chinese medicine enterprises in 2019!
2021-09-14
Ⅰ. The company was rated as "2018 Chuzhou Environmental Protection and Integrity Enterprise".
Ⅱ. Bairui Granules entered the new edition of "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2019 Edition)".
Ⅲ. Zhenyuan Tablet has entered the new version of the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2019 Edition)".
2021-09-14
Ⅰ. The company was recognized as a "high-tech enterprise" for the second time.
Ⅱ. The company was approved to set up "Anhui Postdoctoral Research Station".
Ⅲ. The company was rated as "the city's top ten industrial enterprises in 2017".
Ⅳ. Bairui Granules entered the new edition of "National Essential Medicines List (2018 Edition)".
2021-09-14
Ⅰ. The company was rated as "2016 Excellent Industrial Enterprise of the City".
Ⅱ. The company was recognized as "Provincial Enterprise Technology Center".
Ⅲ. Bairui Granules entered the "National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)".
2021-09-14
Ⅰ. Won the 2015 Langya District Taxation "Top Ten" and "Top Ten" Enterprise Commendation.
Ⅱ. Become an innovative enterprise in Chuzhou City.
Ⅲ. Enpagliflozin products won the 2016 Major Science and Technology Project of Anhui Provincial Department of Science and Technology.
Ⅳ. The "Bomeixing" brand of Bairui preparation was awarded the recognition of famous trademark in Anhui Province.
2021-09-14
Bairui Granules entered the top ten Chinese patent medicines for heat-clearing and detoxification.
2021-09-14
